This report describes the global market size of Neurovascular Catheters Market from 2018 to 2021 and its CAGR from 2018 to 2021, and also forecasts its market size to the end of 2030 and its expected to grow with a CAGR
of 7.19% from 2023 to 2030.
Neurovascular catheters are used in neurovascular surgery to perform interventions in the brain and intracranial spaces. Catheters used for these interventions are specially designed because neurovascular organs are sensitive, and catheter failure or fault can result in vessel damage and perforation.
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Neurovascular Catheters Market estimated at US $ million in the year 2022, is projected to reach a revised size of US$ million by 2030, growing at a CAGR of 7.19% during the forecast period 2023-2030. North American market for Neurovascular Catheters Market is estimated to increase from $million in 2022 to reach $ million by 2030, at a CAGR of XX% during the forecast period of 2023 through 2030.
For geography segment, regional supply, demand, major players, price is presented from 2018 to 2030. This report cover following regions:
Middle East and Africa
The key countries for each regions are also included such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.
For competitor segment, the report include global key players of Neurovascular Catheters Market as well as some small players. The information for each competitor include:
Main Business Information
Sales Volume, Revenue, Price and Gross Margin
In 2022, embolisation catheters had the largest market share of around 28.13%. During a catheter embolisation procedure, embolic agents (drugs or synthetic substances) are injected through a catheter into a specific blood
vessel to block blood flow feeding the tumour or malformation. During the forecast period, the microcatheter segment is expected to grow at the fastest CAGR of 8.4%. Microcatheters are small, hollow tubes used in
neurovascular procedures that are inserted into blood vessels. They are used in a variety of diagnostic and therapeutic cranial procedures to deliver various neurovascular devices to the brain site.
In 2022, the brain aneurysms segment held the largest market share of around 32.79%. Brain aneurysms, also known as intracranial aneurysms, are blood vessel leaks or ruptures that cause bleeding in the brain.
Hypertension, smoking, blood vessel injury or trauma, a complication from a few types of blood infections, and genetic predisposition are all factors that contribute to the formation of intracranial aneurysms. During the forecast
period, the others segment is expected to grow at the fastest CAGR. Moyamoya disease, carotid artery stenosis, and cerebral atherosclerosis are among the other application segments. Moyamoya disease is a rare cerebral
disorder caused by clogged arteries at the brain's base.
By End Use
Ambulatory Surgical Centers
In 2022, the hospital segment held the largest market share of around 55.72%. The increasing patient pool suffering from neurovascular disorders such as ischemic and hemorrhagic stroke, brain aneurysm,
traumatic brain injury (TBI), and arteriovenous malformation (AVM) is primarily responsible for the segment's growth. During the forecast period, ambulatory surgical centres are expected to grow at the fastest CAGR.
When compared to hospitals, ambulatory surgical centres (ASCs) provide several advantages to patients, including shorter procedure times and same-day discharge.
Middle East & Africa
Because of the presence of key manufacturers such as Penumbra, Inc., Stryker Corporation, Merit medical systems, Inc., and Johnson & Johnson in the region,
North America dominated the market with a 32.87% share in 2022. For example, J&J's Cerenovus will invest USD54.19 million in the development of stroke devices at an Irish research facility in February 2022. Due to
factors such as rising target disease burden, technological advancements, and increasing prevalence of neurological disorders, Asia Pacific is expected to grow at the fastest CAGR of 8.23% during the forecast period.
Furthermore, factors such as the presence of key players in the region and rising healthcare expenditure are contributing to the region's growth.
JOHNSON AND JOHNSON SERVICES, INC.
MICROVENTION INC. (TERUMO CORPORATION)
CODMAN NEURO (INTEGRA LIFESCIENCES CORPORATION)
SPIEGELBERG GMBH & CO. KG
Other key players
Please ask for sample pages for full companies list
Base Year: 2022
Historical Data: from 2018 to 2021
Forecast Data: from 2023 to 2030
Any special requirements about this report, please let us know and we can provide custom report.